AlphAIalphai — Financial news for AI agents
GlobeNewswireNOV 52 min read$ICU

SeaStar Medical to Report Third Quarter Financial Results on November 13, 2025

DENVER, Nov. 05, 2025 ( GLOBE NEWSWIRE ) -- SeaStar Medical Holding Corporation ( Nasdaq: ICU ) , a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced today that it will report its third ...

Original reporting
GlobeNewswire · SeaStar Medical
Published Nov 5, 2025, 3:03 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Nov 5, 2025, 3:31 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
SeaStar Medical to Report Third Quarter Financial Results on November 13, 2025 — source image
Source · www.globenewswire.com
Decision brief

The 30-second read

$ICUNeutralLow
01

Why it matters

The upcoming earnings report is a routine event; unless results are significantly different from analyst expectations, minimal market impact is anticipated.

02

Market read

The news has limited immediate trading relevance, primarily affecting short-term trading around the earnings date.

03

What to watch

Market-wide biotech sector movements and broader economic conditions could overshadow company-specific news, influencing stock performance regardless of earnings outcome.

Timing: short-term (within the next 1-2 weeks)

Background

SeaStar Medical is a healthcare company developing treatments for critically ill patients, with a focus on organ failure therapies.

Company-level read

Ticker impact

$ICUNeutralMedium confidence
Context

The upcoming financial report is a quarterly update from SeaStar Medical, which is a healthcare company focused on treatments for critically ill patients. The news is relevant to investors interested in biotech and healthcare sectors.

Expected impact

Potential short-term volatility around the earnings date; no significant long-term price movement expected without surprising results.

Evidence & confidence

The sentiment score is neutral, and the relevance score is moderate (0.41), indicating limited impact. The company's upcoming earnings report is a standard event that may cause short-term trading activity but is unlikely to alter the company's fundamental outlook significantly.

Market effects

Sector

Potential influence on healthcare and biotech sectors if earnings significantly beat or miss estimates.

Regional

Limited regional impact; primarily affects investors and stakeholders in the U.S. healthcare market.

Global

Minimal; the news is company-specific and unlikely to influence global markets.

Counterpoint

What could challenge this read

If SeaStar Medical reports unexpectedly strong results, the stock could experience a short-term rally, presenting a trading opportunity.

Key entities

  • Company
    SeaStar Medical Holding Corporation

    A healthcare company focused on treatments for critically ill patients.

Read at source← All news

Related articles

AUG 13
$ICUMed

SeaStar Medical (ICU) Q2 2026 Earnings Call Transcript

SeaStar Medical Holding Corp (ICU) reported Q2 2026 net revenue of $615,000, up 82% year over year, and six-month net revenue of $1.1 million. Gross margin was 91%. Net loss was $3.7 million ($0.91/share). Cash was $7.0 million at June 30, 2026. QUELIMMUNE adoption reached 20 hospitals; NEUTRALIZE-AKI enrolled 223/339 patients.

fool.com12 min
AUG 12
$ICUMed

SeaStar Medical Holding Corp (ICU): Results of Operations and Financial Condition

SeaStar Medical Holding Corp (ICU) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_973548.htm EXHIBIT 99.1 - Q1 2026 EARNINGS RELEASE ex_973548.htm Exhibit 99.1 SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates Added 3 top-rated children ’ s hospitals to QUELIMMUNE ® pediatric acute kidney injury (AKI) cust

SEC EDGAR 8-K7 min
AUG 13
$RIOTHighAI 9/10

Anthropic Just Paid $9 Billion to Rent a Bitcoin Miner's Power Grid

Anthropic, the developer of Claude, agreed with Riot Platforms to lease 191 MW of computing capacity at Riot’s Rockdale, Texas site for $9.1 billion over 20 years through June 2048, with two five-year extension options that could raise total value to $16.1 billion, according to Riot’s regulatory filing. RIOT shares rose over 25% after the disclosure.

memeburn.com6 min
AUG 13
$BAMed

US jury awards $29 mn damages to Boeing 737 MAX victim's family

A Chicago jury awarded $29 million in damages to the family of Naoise Connolly Ryan, widow of UN engineer Michael Ryan, who died in the 2019 Boeing 737 MAX crash. The civil suit was filed against Boeing. The article notes Boeing apologized and said anti-stall software was implicated. It cites another $49.5 million award in May.

bssnews.net2 min
AUG 13
$BAMed

Jury awards $29m to Irishman's family after plane crash

A Chicago jury awarded $29m to the family of Naoise Connolly Ryan, widow of UN employee Micheál “Mick” Ryan, who died in the 2019 Boeing 737 MAX crash. The civil suit was filed against Boeing. Boeing has apologized and said anti-stall software was implicated. The case is among remaining MAX civil suits.

rte.ie3 min
AUG 13
$RIOTMed

B. Riley keeps Riot at Buy after $9.1 billion Rockdale AI lease

B. Riley Securities reiterated a Buy rating and $28 price target for Riot Platforms (RIOT), citing a 20-year Rockdale, Texas AI data center lease. The initial 191 MW lease is expected to generate about $9.1 billion in contract revenue through June 2048. Riot reported Q2 revenue of $174.2 million (+14% YoY) and expects MW to come online from Dec 2027 to June 2028.

yahoo.com4 min